Different approaches for delivering the drug through vesicular carriers

Authors

  • Abhijeet Ojha DIT University, Faculty of Pharmacy, Makkawala, Mussoorie Diversion Road, Dehradun, India
  • Yashika Sharma DIT University, Faculty of Pharmacy, Makkawala, Mussoorie Diversion Road, Dehradun, India

DOI:

https://doi.org/10.21276/IJRDPL.2278-0238.2018.7(4).3071-3082

Keywords:

Liposomes, Niosomes, Aquasomes, Phytosomes, vesicular carriers

Abstract

Delivering the drug molecule through conventional ways of drug delivery has been a challenging task for the researchers since years. Many novel technologies and system have been developed to overcome this limitation. Vesicular carriers such as niosomes, liposomes, aquasomes, phytosomes, etc. have been developed as one of the novel ways for the delivery of drug molecules effectively. They provide various advantages such as increased bioavailability, increased pharmacological activity, decreased toxicity, enhancement of stability, sustained delivery, and protection from physical and chemical degradation that occurs inside the body over conventional delivering systems. These vesicular systems can be lipidic or non- lipidic. The composition of niosomes involves nonionic surfactants- lipids and liposome involves phospholipids (natural and synthetic). This review article describes the study of the four vesicular carriers namely niosomes, liposomes, aquasomes and phytosomes and their various aspects such as their definition, types, methods of preparation, advantages, disadvantages, evaluation and characterization. Such different systems are widely used in gene delivery, tumor targeting to brain, oral formulations, in stability and permeability problems of drugs.

Downloads

Download data is not yet available.

References

https://www.frontiersin.org/articles/10.3389/fphar.2015.00286/full

Rege K, Huang HC, Barua S, Sharma G, Dey SK. Inorganic nanoparticles for cancer imaging and therapy. Int J Pharm 2006; 309:227-33. Control Release 2011;155:344-57.

Patil S, Pancholi SS, Agrawal S, Agrawal GP. Surface-modified mesoporous ceramics as delivery vehicle for haemoglobin. Drug Delivery 2004;1:193-9.

Kommineni S, Ahmad S, Vengala P, Subramanyam CV. Sugar coated ceramic nanocarriers for the oral delivery of hydrophobic drugs: Formulation, optimization and evaluation. Drug Dev Ind Pharm 2012;38:577-86.

Priyanka R Kulkarni, Jaydeep D Yadav, Kumar A Vaidya. Liposomes: A Novel Drug ?Delivery System. Int J Curr Pharm Res, 2011; 3(2): 10-18. ?

Goyal AK, Rawat A, Mahor S, Gupta PN, Khatri K, Vyas SP. Nanodecoy system: A novel approach to design hepatitis B vaccine for immunopotentiation.

Goyal AK, Rawat A, Mahor S, Gupta PN, Khatri K, Vyas SP. Nanodecoy system: A novel approach to design hepatitis B vaccine for immunopotentiation. Int J Pharm 2006;309:227-33.

http://www.asiapharmaceutics.info/index.php/ajp/article/viewFile/61/184

Mascarella S. Therapeutic and Antilipoperoxidant Effects of Silybin?Phosphatidylcholine Complex in Chronic Liver Disease, Preliminary Results. CurrTher Res 1993; 53: 98?102.

Jain N. Phytosome: A Novel Drug Delivery System for Herbal Medicine. International Journal of Pharmaceutical Sciences and Drug Research 2010; 2:224?228.

Kidd PM and Head K. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos®). AlterMed Rev 2005; 10: 193-203.

Franco PG, Bombardelli E. Complex compounds of bioflavonoids with phospholipids, their preparation and uses and pharmaceutical and cosmetic compositions containing them. U.S. Patent No?EPO 275005; 1998

Choubey A. Phytosome: A Novel approach for Herbal Drug Delivery. International Journal of Pharmaceutical Sciences and Research 2011; 2:807?815.

Bombardelli E, Mustich G. Bilobalide phospholipid complex, their uses and formulation containing them, U.S. Patent US EPO?275005; 1991.

Franco PG, Bombardelli E. Complex compounds of bioflavonoids with phospholipids, their preparation and uses and pharmaceutical and cosmetic compositions containing them. U.S. Patent No?EPO 275005; 1998.

Mansoori M.A., Agrawal S., Jawade S., Khan M. I. 'A Review on Liposome'. International Journal of Advanced Research in Pharmaceutical and Biosciences, 2012; 2(4): 453-467.

K.Torchilin. 'Recent Advances with Liposomes as Pharmaceutical Carriers'. Drug Discovery, 2005; 4: 145-160?

N.K.Jain. Controlled And Novel Drug Delivery. 2nd Edition CBS Publication., 304-343

Kant Shashi, Kumar Satinder,PrasharBharat.'A Complete Review on: Liposomes'. International Research Journal Of Pharmacy, 2012; 3(7): 10-6.

Anna Jone . Liposomes: A short Review. J. Pharm. Sci. & Res., 2013; 5(9): 181-3.

Saraswathi Marripati, K. Umasankar, P. Jayachandra Reddy. A Review on Liposomes. International Journal of Research in Pharmaceutical and Nano Sciences, 2014; 3(3): ?159 - 169.?

Amarnath Sharma, Uma S. Sharma. Liposomes in drug delivery: progress and limitations. ?International Journal of Pharmaceutics, 1997; 154: 123-140.

Priyanka R Kulkarni, Jaydeep D Yadav, Kumar A Vaidya. Liposomes: A Novel Drug Delivery System. Int J Curr Pharm Res, 2011; 3(2): 10-18.

V. Pola Chandu et.al, Niosomes a novel drug ddelivery system, February 29, 2012

https://openi.nlm.nih.gov/detailedresult.php?img=PMC4065701_BMRI2014-263604.002&req=4

Biju SS., Talegaonkar S., Misra PR., Khar RK., Vesicular systems: An overview. Indian J. Pharm. Sci. 2006, 68: 141-153.

Yoshida H., Lehr, C.M., Kok W., Junginger H.E., Verhoef J.C., Bouwistra J.A. Niosomes for oral delivery of peptide drugs. J.Control Rel.1992; 21: 145-153.

Satturwar, P.M., Fulzele, S.V., Nande, V.S., Khandare, J.N., Formulation and evaluation of ketoconazole Niosomes. Indian J.Pharm, 2002; 64 (2): 155-158.

Vyas S.P., Khar R, K., Niosomes Targeted and Controlled Drug delivery, 2008; 249 - 279.

Gibaldi .M and Perrier D; Pharmacokinetics, second edition, New York, Marcel Dekker, Inc., 1982; 127-134.

Namdeo, A., Jain, N.K., Niosomal delivery of 5-fluorouracil. J. Microencapsul. 1999; 16 (6): 731 - 740.

Bhaskaran S., Panigrahi L., Formulation and Evaluation of Niosomes using Different Nonionic Surfactant. Ind J Pharm Sci. 2002, 63: 1-6.

Balasubramanian A., Formulation and In-Vivo Evaluation of Niosome Encapsulated Daunorubicin Hydrochloride. Drug Dev and Ind.Pharm. 2002, 3(2): 1181-84.

Schreier H., Liposomes and niosomes as topical drug carriers: dermal and transdermal delivery. J. Controlled Release. 1985; 30: 863-868.

Buckton G., Harwood, Interfacial phenomena in Drug Delivery and Targeting Academic Publishers, Switzerland. 1995, 154-155.

Hunter C.A., Dolan T.F., Coombs G.H., Baillie A.J, Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J.Pharm. Pharmacol. 1988, 40(3): 161-165.

Bairwa N. K., Choudhary Deepika., Proniosome: A review, Asian Journal of Biochemical and Pharmaceutical Research. 2011, 2 (1): 690-694.

Suzuki K., Sokan K., The Application of Liposome's to Cosmetics. Cosmetic and Toiletries. 1990, 105: 65-78.

Anna Pratima Nikalje* Department of Pharmaceutical chemistry, Y.B. Chavan College of Pharmacy, Dr. Rafiq Zakaria Campus, Rauza Bagh, Aurangabad- 431001, Maharashtra, India Nikalje, Med chem 2015, 5:2.

Published

2018-08-15

How to Cite

Ojha, A. ., & Sharma, Y. . (2018). Different approaches for delivering the drug through vesicular carriers. International Journal of Research and Development in Pharmacy & Life Sciences, 7(4), 3071 - 3082. https://doi.org/10.21276/IJRDPL.2278-0238.2018.7(4).3071-3082